| mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.4 |
1e-30 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
8e-20 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-15 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-10 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-09 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-07 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |